Ethnicity questions and antenatal screening for sickle cell/thalassaemia [EQUANS] in England: a randomised controlled trial of two questionnaires
- PMID: 16595318
- DOI: 10.1080/13557850500460348
Ethnicity questions and antenatal screening for sickle cell/thalassaemia [EQUANS] in England: a randomised controlled trial of two questionnaires
Abstract
Concepts allied to ethnicity are increasingly coming under question as legitimate variables for use in health research. A randomised controlled trial of two ethnicity screening questions for ascertaining risk of carrying genes associated with sickle cell and thalassaemia illustrates the challenges and limitations of assessing an association of social constructs and genetic statuses.
Objectives: To evaluate two candidate ethnicity screening questions in antenatal screening programmes in low, mixed and high sickle cell prevalence areas, and to identify time taken in administration of the questions by use of the following measures: (1) Proportions of respondents with missing ethnicity data and/or significant changes in ethnic/family origins upon re-interview. (2) Numbers of carriers of clinically significant haemoglobin disorders missed by ethnicity screening questions. (3) Time taken to explain screening question for sickle cell disease (SCD)/thalassaemia and obtain ethnic/family origins. (4) Proportion of clients providing usable ethnic/family origins data. (5) Reported ethnic/family origins in pregnant women at first booking with midwife.
Design: Ten-month (September 2002-June 2003) questionnaire study with random allocation to two self-administered ethnicity questions, comparison with laboratory results and results from re-interview. The settings were antenatal booking clinics in four geographical areas of England of varying expected foetal prevalence of SCD: very high (29.75 per 10,000 pregnancies); high (8.2); mixed high and low (1.29); and low (0.18). The subjects were 4,559 pregnant women at first booking with midwife.
Results: Proportions of respondents with missing ethnicity data and/or significant changes in ethnic/family origins upon re-interview were 4.33% (CI 2.63-6.68%) for a category-based question and 9.45% (CI 6.86-12.61%) for a binary plus open-ended question. Proportions of carriers missed were 5.74% (CI 2.34-11.46%) and 9.71% (CI 4.75-17.13%) by category-based and binary plus open-ended questions, respectively. Average time taken to ascertain ethnic/family origins for screening was between 2.17 and 5.12 minutes in different areas, and up to 15 minutes at the 95th centile. Usable ethnicity screening data was missing in 2.94% of instances. Errors in interpretation or missing data were 3.2% for a category-based question and 4.71% for a binary plus open-ended ethnicity question. Ethnicity Question A produces fewer cases of missing or misinterpreted data (p < 0.001).
Conclusions: A category-based ethnicity screening question was more effective than a binary plus open-ended question. Using the more effective question, 5.74% (CI 2.34-11.46%) of significant haemoglobinopathies will be missed in a selective screening programme, and 4.33% (CI 2.63-6.68%) of replies to an ethnicity screening question will be unreliable when compared to information given upon re-interview. In specific carefully circumscribed situations, namely, in antenatal screening for sickle cell and thalassaemia, it is possible to measure the degree of association between social constructs of ethnicity and health status in a manner that may help in effecting policy decisions.
Similar articles
-
Antenatal thalassaemia carrier testing: women's perceptions of "information" and "consent".J Med Screen. 2005;12(2):69-77. doi: 10.1258/0969141053908258. J Med Screen. 2005. PMID: 15949117
-
Sickle cell and thalassaemia: screening for all.Pract Midwife. 2007 Apr;10(4):22-4. Pract Midwife. 2007. PMID: 17476893 No abstract available.
-
The feasibility of using ethnicity as a primary tool for antenatal selective screening for sickle cell disorders: pointers from the research evidence.Soc Sci Med. 2003 Jan;56(2):285-97. doi: 10.1016/s0277-9536(02)00027-8. Soc Sci Med. 2003. PMID: 12473314
-
[Monitoring pregnant patients from risk countries with sickle cell disease and thalassemia. Clinical aspects, screening and prenatal diagnosis].Geburtshilfe Frauenheilkd. 1993 Apr;53(4):215-21. doi: 10.1055/s-2007-1023668. Geburtshilfe Frauenheilkd. 1993. PMID: 8491363 Review. German.
-
Sickling syndromes in children.Adv Pediatr. 1976;23:271-313. Adv Pediatr. 1976. PMID: 795281 Review.
Cited by
-
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.Cochrane Database Syst Rev. 2018 Mar 14;3(3):CD010849. doi: 10.1002/14651858.CD010849.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2021 Oct 11;10:CD010849. doi: 10.1002/14651858.CD010849.pub4. PMID: 29537064 Free PMC article. Updated.
-
Offering antenatal sickle cell and thalassaemia screening to pregnant women in primary care: a qualitative study of women's experiences and expectations of participation.Health Expect. 2012 Jun;15(2):115-25. doi: 10.1111/j.1369-7625.2011.00669.x. Epub 2011 Mar 3. Health Expect. 2012. PMID: 21366810 Free PMC article.
-
'A morass of considerations': exploring attitudes towards ethnicity-based haemoglobinopathy-carrier screening in primary care.Fam Pract. 2013 Oct;30(5):604-10. doi: 10.1093/fampra/cmt019. Epub 2013 Apr 29. Fam Pract. 2013. PMID: 23629736 Free PMC article.
-
Haemoglobinopathies in Europe: health & migration policy perspectives.Orphanet J Rare Dis. 2014 Jul 1;9:97. doi: 10.1186/1750-1172-9-97. Orphanet J Rare Dis. 2014. PMID: 24980780 Free PMC article.
-
Attitudes of general practitioners and midwives towards ethnicity-based haemoglobinopathy-carrier screening.Eur J Hum Genet. 2012 Nov;20(11):1112-7. doi: 10.1038/ejhg.2012.72. Epub 2012 May 2. Eur J Hum Genet. 2012. PMID: 22549405 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical